Northfield Email Format
Biotechnology ResearchUnited States51-200 Employees
Northfield is a United States–based biotechnology research company focused on developing blood substitute technology. Its lead product candidate, PolyHeme, is intended for use when a red blood cell transfusion is needed but compatible donor cells are unavailable or unsuitable. PolyHeme consists of chemically modified human hemoglobin and does not require cross-matching, making it compatible with all blood types. The formulation is described as having a shelf life exceeding 12 months. Operating in the biotechnology research sector, Northfield aims to provide alternative transfusion options to address blood supply constraints. The company is based in the United States and comprises a mid-sized team.